Deutsche Bank’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Deutsche Bank’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,295	Closed	-$418K	–	5524
2014 Q4	$418K	Buy	8,295 +900	+12%	+$43.9K	﹤0.01%	3795
2014 Q3	$345K	Sell	7,395 -1,200	-14%	-$54.2K	﹤0.01%	3741
2014 Q2	$386K	Buy	8,595 +183	+2%	+$7.87K	﹤0.01%	3671
2014 Q1	$355K	Buy	8,412 +1,929	+30%	+$80.9K	﹤0.01%	3540
2013 Q4	$254K	Buy	+6,483	New	+$243K	﹤0.01%	3552

Other funds holding IHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BWM

Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

Deutsche Bank's IHE Position: Q1 2015 in Review

Deutsche Bank sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2015, closing a stake of 8,295 shares — an estimated $418K sold.

Deutsche Bank first reported a position in IHE in Q4 2013 and held it in 5 quarters. The position peaked at $418K in Q4 2014. 111 funds tracked by Wall St. Rank hold IHE as of Q1 2015.

Deutsche Bank reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 8,295 iShares US Pharmaceuticals ETF shares in Q1 2015, an estimated $418K.
Deutsche Bank first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and held it in 5 quarters.
Deutsche Bank's iShares US Pharmaceuticals ETF position peaked at $418K in Q4 2014.
111 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.